Processa Pharmaceuticals, Inc. Proceeds from Sale of Other Assets
Processa Pharmaceuticals, Inc. (PCSA) reported Proceeds from Sale of Other Assets of $17.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-09-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. proceeds from sale of other assets for the quarter ending 2016-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. proceeds from sale of other assets for the quarter ending 2016-09-30 was -$25.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of other assets for the quarter ending 2016-06-30 was $15.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of other assets for the quarter ending 2016-03-31 was $27.00K.
- Processa Pharmaceuticals, Inc. proceeds from sale of other assets for fiscal 2016 was $17.00K.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 6 month | Proceeds from Sale of Other Assets 9 month | Proceeds from Sale of Other Assets 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$25.00K derived: sum of 2 quarters · filed 2017-11-20 | -$10.00K derived: sum of 3 quarters · filed 2017-11-20 | $17.00K 10-K · filed 2017-09-25 |
| 2016-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$10.00K derived: sum of 2 quarters · filed 2017-11-20 | $17.00K 10-Q · filed 2017-11-20 | |
| 2016-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $42.00K 10-Q · filed 2017-10-04 | ||
| 2016-03-31 | $27.00K 10-Q · filed 2017-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |